Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

Jampol Lee M.; Glassman Adam R.; Liu Danni; Aiello Lloyd Paul; Bressler Neil M.; Duh Elia J.; Quaggin Susan; Wells John A.; Wykoff Charles C.

首页> 外文期刊>Ophthalmology >Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

【24h】

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

机译：血管内皮生长因子治疗糖尿病黄斑水肿后血浆血管内皮生长因子浓度

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose: To assess systemic vascular endothelial growth factor (VEGF)-A levels after treatment with intravitreous aflibercept, bevacizumab, or ranibizumab.

机译：目的：用膀胱内酯AfliBercept，Bevacizumab或Ranibizumab治疗后评估全身血管内皮生长因子（VEGF）-A水平。

著录项

来源
《Ophthalmology》 |2018年第7期|共10页
作者
Jampol Lee M.; Glassman Adam R.; Liu Danni; Aiello Lloyd Paul; Bressler Neil M.; Duh Elia J.; Quaggin Susan; Wells John A.; Wykoff Charles C.;
展开▼
作者单位

Northwestern Univ Feinberg Sch Med Chicago IL 60611 USA;

Jaeb Ctr Hlth Res 15310 Amberly Dr Suite 350 Tampa FL 33647 USA;

Jaeb Ctr Hlth Res 15310 Amberly Dr Suite 350 Tampa FL 33647 USA;

Harvard Dept Ophthalmol Beetham Eye Inst Joslin Diabet Ctr Boston MA USA;

Johns Hopkins Univ Sch Med Wilmer Eye Inst Baltimore MD 21205 USA;

Johns Hopkins Univ Sch Med Wilmer Eye Inst Baltimore MD 21205 USA;

Northwestern Univ Feinberg Sch Med Chicago IL 60611 USA;

Palmetto Retina Ctr Columbia SC USA;

Blanton Eye Inst Retina Consultants Houston Houston TX USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema [J] . Jampol Lee M., Glassman Adam R., Liu Danni, Ophthalmology . 2018,第7期

机译：血管内皮生长因子治疗糖尿病黄斑水肿后血浆血管内皮生长因子浓度
2. Factors affecting compliance to intravitreal anti-vascular endothelial growth factor therapy in Indian patients with retinal vein occlusion, age-related macular degeneration, and diabetic macular edema [J] . Aditya Kelkar, Caroll Webers, Rohit Shetty, Indian Journal of Ophthalmology . 2020,第10期

机译：影响含有玻璃体内抗血管内皮生长因子治疗的因素在印度静脉闭塞，年龄相关黄斑变性和糖尿病黄斑水肿中的印度患者
3. Baseline Predictive Factors in Diabetic Macular Edema Treated With Anti-Vascular Endothelial Growth Factor Therapy [J] . Sivaprasad Sobha JAMA ophthalmology . 2019,第4期

机译：抗血管内皮生长因子治疗治疗糖尿病黄斑水肿的基线预测因素
4. Endothelial Cell Migration In Platelet Poor Plasma: Synergistic Effects Between Vascular Endothelial Growth Factor And Sphingosine 1-phosphate [C] . S. Hughes, B.K. Wacker, M.M. Kaneda, Society for Biomaterials Transactions 30th Annual Meeting & Exposition vol.28: New Applications and Technologies . 2005

机译：血小板在贫血血浆中的内皮细胞迁移：血管内皮生长因子和鞘氨醇1-磷酸之间的协同效应。
5. Arterial Thromboembolic Events following Intravitreal Vascular Endothelial Growth Factor Inhibitor Therapy for Age-Related Macular Degeneration in Regular Clinical Practice. [D] . Fafowora, Oluwatoyin Folasade. 2015

机译：在常规临床实践中，玻璃体内血管内皮生长因子抑制剂治疗与年龄相关的黄斑变性的动脉血栓栓塞事件。
6. Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema [O] . Davis Bhagat, Breanne Kirby, Harit Bhatt, 2020

机译：与抗血管内皮生长因子疗法相关的患者偏好用于新生血管年龄相关的黄斑变性和糖尿病黄斑水肿
7. Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Clinical Practice of Single Center: Three-Year Outcomes [O] . Janejit Choovuthayakorn, Phichayut Phinyo, Apichat Tantraworasin, 2020

机译：玻璃体内抗血管内皮生长因子治疗单中心临床实践中的糖尿病性黄斑水肿：三年成果

Plasma Vascular Endothelial Growth Factor Concentrations after Intravitreous Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema

摘要

著录项

相似文献

相关主题

期刊订阅